R&D Dark factories for a bright future Much like medicine itself, drug manufacturing has evolved rapidly over recent decades.
Digital Redefining pharmaceutical case processing in the age of AI a... Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to
R&D Transforming clinical data management systems for biotechnol... In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.
Digital The future of pharmacovigilance – beginning the shift to AI-... In 2023, the pharmaceutical industry saw a surge in innovation.
Digital Generative AI and its impact on speed to market for pharmace... Generative AI (GenAI) is revolutionising the life sciences, and we’re just scratching the surface.
Digital Digitisation of drug R&D: Avoiding new for novelty’s sake AI and wearable medical devices are already advancing patient care, and transformative use of data and digital innovation is set to enable a new generation of medicines, faster.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
